Jump Financial, LLC Onconova Therapeutics, Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.46 - $2.82 $33,845 - $65,373	-23,182 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.49 - $3.73 $57,723 - $86,468	23,182 New	23,182 $59,000
Q3 2021 Nov 12, 2021	SELL	$3.81 - $6.76 $70,485 - $125,060	-18,500 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$6.28 - $16.2 $116,180 - $299,700	18,500 New	18,500 $128,000

249K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.